Stock Ticker

  • Loading stock data...

Boston Scientific Corporation (NYSE:BSX) Asked To Pay $308 Million In Patent Infringement Case

Boston, MA 09/26/2014 (wallstreetpr) – Boston Scientific Corporation (NYSE:BSX) announced receiving a negative decree from a court that demands the company to pay as much as $308 million in patent infringement case. Unfavorable Verdict According to an article, the medical equipment manufacturer has been ruled to pay the sum of $308 million on pretext of […]

Goldman Sachs Group Inc (NYSE:GS) Key Takeaways from Transcatheter Cardiovascular Therapeutics Conference

Boston, MA 09/16/2014 (wallstreetpr) – Investment advisor, Goldman Sachs Group Inc (NYSE:GS) analysts have provided key takeaways from the 2014 Transcatheter Cardiovascular Therapeutics or TPT conference. Accordingly, they have retained their Buy rating on the shares of Abbott Pharmaceuticals (NYSE:ABT) and Edwards Lifesciences Corp (NYSE:EW) while they remained Neutral on St. Jude Medical, Inc. (NYSE:STJ) […]

Is Boston Scientific Corporation (NYSE:BSX) Heading For A further Fall As Insider Sells Shares?

Boston, MA 06/10/2014 (wallstreetpr) – Shares of medical device maker Boston Scientific Corporation (NYSE:BSX) tanked on Monday with volume doubling from the preceding week triggering speculation whether it is heading for a further fall. Interestingly, a director of the company sold part of his holding in the open market on June 2. Insider Trading The […]

Boston Scientific Corporation (NYSE:BSX) Reports Positive Data On Evolve Trial

Boston, MA 05/23/2014 (wallstreetpr) – Innovative medical solutions provider, Boston Scientific Corporation (NYSE:BSX) announced that it could see positive performance on EVOLVE clinical study. The company disclosed that it continues to indicate assurance about safety and efficacy. Evolve The company revealed a favorable follow-up data during the three year period on EVOLVE clinical study that […]

Boston Scientific Corporation (NYSE:BSX) Brings BP Lowering Device

Boston, MA 10/29/2013 (wallstreetpr) – Boston Scientific Corporation (NYSE:BSX) has good news for hypertension or high blood pressure patients. Its new equipment called – Vessix- will now allow doctors to treat hypertension patients, who no longer respond to medical treatment. The procedure using Vessix will allow doctors to now lower blood pressure to normal measurements. Such […]

Boston Scientific Corporation (NYSE:BSX) announces worldwide layoffs

Boston Scientific Corporation (NYSE:BSX) has announced plans to lay off as much as 6% of its total work force numbering to around 1500 jobs all around the world. This is the latest cost cutting announcement made by the company which also announced recently that the CFO of the company will be leaving soon. This medical […]

Boston Scientific Corporation (NYSE:BSX) To Cut 1500 Jobs Even With Narrower Quarterly Losses

Boston, MA 10/25/2013 (wallstreetpr) – It seems that the mistake of 2005 will continue to haunt Boston Scientific Corporation (NYSE:BSX) forever. The company’s profit and loss accounts have bled for last 8 years since the time company decided to purchase heart implant maker Guidant for an eye-popping $27 billion. And that was the last time company […]

Unending Court Cases For Boston Scientific Corporation (NYSE:BSX)

Boston, MA 10/23/2013 (wallstreetpr) – Over the last three months, Boston Scientific Corporation (NYSE:BSX) has traded an average of 15 million shares a day. However on Monday October 21, the company traded just 9 million shares but managed to set a 52 week high of $12.48 and has a low of $5.04. This is a 3.45% gain […]

Boston Scientific Corporation (NYSE:BSX) Scrip Reads Hold

Boston, MA 10/17/2013 (wallstreetpr) – Boston Scientific Corporation (NYSE:BSX), much like other medical device manufacturers, has seen dwindling sales and contracting revenues for quite some time now. The medical devices market has for along time now remained weak owing to a number of constraints in the industry. Amid these challenges, analysts have recently reviewed the […]

Boston Scientific Corporation (NYSE:BSX)’s Shares Surge Ahead of Quarterly Results

Boston, MA 10/15/2013 (wallstreetpr) – Boston Scientific Corporation (NYSE:BSX) has been trading in green ahead of its third quarter earnings to be declared on October 24’2013. It has been a view that the company is engaged in a revival attempt which could be reflected in its second quarter results as well. The company which is a […]

Boston Scientific Corporation (NYSE:BSX) Shows Revival Efforts

Boston, MA 10/14/2013 (wallstreetpr) –  After several quarters of lackluster performance, Boston Scientific Corporation (NYSE:BSX) has begun showing encouraging revival efforts. This is well captured in its Q2.13 results. In the earnings for the most recent quarter, BSX posted $0.18 in EPS, smashing the consensus %0.16 and climbing over $0.17 EPS in the comparable quarter a […]

Sunshine Heart (NASDAQ:SSH) Device Receives Approval From FDA- SSH, ABMD, BSX, SPNC, EW

Sunshine Heart Inc (NASDAQ:SSH) announced on Tuesday that it got unconditional authorization from the Food and Drug Administration to start its pivotal U.S. trial for its flagship C-Pulse Heart Assist System. Shares climbed 17 percent premarket to $7.74. As of Monday’s close, the stock was dropped 4.5 percent over the previous three months. Accordant to […]

Sign Up To Get Our Latest Stocks Alerts